The quest for more understanding is behind the single use boom: Pall and Thermo Fisher

Single use tech for biopharma: Pall and Thermo Fisher

The implementation of single use technology in the biopharmaceutical fill and finish process has seen a massive uptick recently because of better industry understanding, according to Pall’s Bruce Rawlings.

Citing Aspen Brook’s annual survey of the bioprocessing market for single use, Rawlings said that there were no companies using the tech for fill and finish activities in 2010, but that by 2011 54 per cent were using it in their systems.

He said the boom is a result of a better industry understanding of leachables and extractables.

Speaking to in-PharmaTechnologist.com at this year’s Achema in Germany, Rawlings – Pall’s biopharma product manager – said: “The biggest barrier for single use in the past would probably have been understanding of the requirements for extractables and leachables.

“People’s knowledge levels of the users, the suppliers and the regulators have increased significantly in that area, and that has given people the confidence to implement it on higher ends of the process.”

He added that regulatory pressures on users to present data about the implementation of single use technology has been a big driving factor behind the quest for a greater understanding.

Rawlings also said that though most application for single use lie in clinical and pilot areas, filling has embraced the platform for larger production lines. “Because you’re on the far end of process where the volumes are quite small anyway, filling fits very well with single use technologies,” he said.

Changes in the lab

Going back to Aspen Brook’s survey, Rawlings also remarked a rise of disposable equipment for centrifugation – which saw a more modest incline of two per cent in 2010, to 27 per cent in 2011.

However, he predicted the rise has now hit a ceiling because it is too pricey to produce the large disposable bottles needed for big scale separation.

“My personal opinion would be that centrifugation tends to be in the upstream area of the process, volumes tend to be quite large,” he said.

When in-PharmaTechnologist.com asked ThermoFisher’s product specialist for centrifugation Ulrich Schleiswhether this was the case, he confirmed that producing big tubes of enough quality cheaply is a problem.

But he added there could be a light at the end of the tunnel, predicting further developments over the next five years.

He added: “I guess many customers have problems with cleaning the tubes and saving costs, but the single use tubes are always clean enough and always ready to go.”

Related News

Catalent to replace steel bioreactors with single use

Catalent plans single use overhaul of bioreactors

Pall opens US centre of excellence

Pall sets up systems 'proving ground'; signs India deal with Avacta

Pall To Open Centre of Excellence in UK

Pall To Open Centre of Excellence in UK

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Thermo Fisher Scientif Speak Single Use at Interphex, New York

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Single-Use Growth Offsets Pall's Muted Results

Single-Use Growth Offsets Pall's Muted Results

New Pall single-use TFF tech attracts attention

New Pall single-use TFF tech attracts attention

Thermo Fisher awaits monopoly commissions decisions on $13.6bn Life Tech acquisition

Thermo Fisher awaits regulatory nod for Life Tech acquisition

So far, so very good: Pall and ATMI talk integration at interphex

So far, so very good: Pall and ATMI talk integration at interphex

Extractables & leachables a barrier to single-use tech adoption says China's Wuxi Apptech

Extractables & leachables the biggest barrier to SU adoption, says WuXi

Thermo Fisher has $15bn of disposable capital, with $10bn set on M&A in the life sciences sector

Thermo Fisher's $15bn war chest set to further consolidate industry

HP production: add water before cleaning says Bosch

‘Just add water’ for ease of cleaning HP production tech, says Bosch

UPDATE: Last leg of Achema

Achema 2012: Safety, efficiency and single-use technology

Single-use drug production tech: ATMI

ATMI gears up for single-use "boom" for biotech industry

The single-use age has dawned, says ThermoFisher

The single-use age has dawned, says ThermoFisher

EMD Millipore talks single use technology at Interphex 2011

EMD Millipore talks single use technology at Interphex 2011

Single-use bioprocess demand drives Sartorius’ sales jump

Single-use bioprocess demand drives Sartorius’ sales jump

Related Products

See more related products